These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8282270

  • 1. [Inhibitory action of E3810 on H+,K(+)-ATPase and gastric acid secretion in vitro].
    Fujisaki H, Oketani K, Shibata H, Murakami M, Fujimoto M, Wakabayashi T, Yamatsu I, Takeguchi N.
    Nihon Yakurigaku Zasshi; 1993 Dec; 102(6):389-97. PubMed ID: 8282270
    [Abstract] [Full Text] [Related]

  • 2. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.
    Fujisaki H, Shibata H, Oketani K, Murakami M, Fujimoto M, Wakabayashi T, Yamatsu I, Yamaguchi M, Sakai H, Takeguchi N.
    Biochem Pharmacol; 1991 Jul 05; 42(2):321-8. PubMed ID: 1650210
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The potency of substituted benzimidazoles such as E3810, omeprazole, Ro 18-5364 to inhibit gastric H+, K(+)-ATPase is correlatedwith the rate of acid-activation of the inhibitor.
    Morii M, Takata H, Fujisaki H, Takeguchi N.
    Biochem Pharmacol; 1990 Feb 15; 39(4):661-7. PubMed ID: 2154989
    [Abstract] [Full Text] [Related]

  • 5. Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently.
    Tomiyama Y, Morii M, Takeguchi N.
    Biochem Pharmacol; 1994 Nov 29; 48(11):2049-55. PubMed ID: 7802694
    [Abstract] [Full Text] [Related]

  • 6. The proton pump inhibitor, E3810, binds to the N-terminal half of the alpha-subunit of gastric H+,K(+)-ATPase.
    Morii M, Hamatani K, Takeguchi N.
    Biochem Pharmacol; 1995 Jun 16; 49(12):1729-34. PubMed ID: 7598734
    [Abstract] [Full Text] [Related]

  • 7. Different biochemical modes of action of two irreversible H+,K(+)-ATPase inhibitors, omeprazole and E3810.
    Morii M, Takeguchi N.
    J Biol Chem; 1993 Oct 15; 268(29):21553-9. PubMed ID: 8408006
    [Abstract] [Full Text] [Related]

  • 8. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.
    Besancon M, Simon A, Sachs G, Shin JM.
    J Biol Chem; 1997 Sep 05; 272(36):22438-46. PubMed ID: 9278394
    [Abstract] [Full Text] [Related]

  • 9. An ascending single-dose safety and tolerance study of an oral formulation of rabeprazole (E3810).
    Lew EA, Barbuti RC, Kovacs TO, Sytnic B, Humphries TJ, Walsh JH.
    Aliment Pharmacol Ther; 1998 Jul 05; 12(7):667-72. PubMed ID: 9701531
    [Abstract] [Full Text] [Related]

  • 10. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
    Nishioka K, Nagao T, Urushidani T.
    Biochem Pharmacol; 1999 Oct 15; 58(8):1349-59. PubMed ID: 10487539
    [Abstract] [Full Text] [Related]

  • 11. New fluorescent probes E3810 and methoxy E3810 for determining distributions of the apical membrane and the acidic compartment of gastric acid secreting cells.
    Takeguchi N, Yamanouchi T, Sakai H, Morii M.
    Jpn J Physiol; 1992 Oct 15; 42(1):75-88. PubMed ID: 1320706
    [Abstract] [Full Text] [Related]

  • 12. Oligomeric regulation of gastric H+,K+-ATPase.
    Morii M, Hayata Y, Mizoguchi K, Takeguchi N.
    J Biol Chem; 1996 Feb 23; 271(8):4068-72. PubMed ID: 8626741
    [Abstract] [Full Text] [Related]

  • 13. Pantoprazole: a novel H+/K(+)-ATPase inhibitor with an improved pH stability.
    Beil W, Staar U, Sewing KF.
    Eur J Pharmacol; 1992 Aug 06; 218(2-3):265-71. PubMed ID: 1330598
    [Abstract] [Full Text] [Related]

  • 14. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
    Simon WA, Keeling DJ, Laing SM, Fallowfield C, Taylor AG.
    Biochem Pharmacol; 1990 Jun 01; 39(11):1799-806. PubMed ID: 2160820
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
    Uchiyama K, Wakatsuki D, Kakinoki B, Takeuchi Y, Araki T, Morinaka Y.
    J Pharm Pharmacol; 1999 Apr 01; 51(4):457-64. PubMed ID: 10385219
    [Abstract] [Full Text] [Related]

  • 20. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D, Chae JB, Park CW, Kim YS, Lee SM, Kim EJ, Huh IH, Kim DY, Cho KD.
    Arzneimittelforschung; 2001 Apr 01; 51(3):204-13. PubMed ID: 11304936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.